| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 24.328 | 31.644 | 35.411 | 35.734 | 30.813 | 37.955 | 47.546 | 58.486 | 64.599 |
| Total Income - EUR | - | 24.328 | 31.644 | 35.411 | 35.734 | 30.813 | 37.955 | 47.546 | 68.594 | 64.599 |
| Total Expenses - EUR | - | 7.826 | 15.031 | 19.473 | 19.430 | 19.433 | 22.210 | 18.970 | 31.871 | 39.849 |
| Gross Profit/Loss - EUR | - | 16.502 | 16.613 | 15.938 | 16.304 | 11.380 | 15.745 | 28.576 | 36.723 | 24.750 |
| Net Profit/Loss - EUR | - | 15.927 | 16.258 | 15.581 | 15.849 | 11.073 | 15.365 | 28.101 | 36.037 | 22.812 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ralvita Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 10 | 16.535 | 11.805 | 7.235 | 2.839 | 0 | 0 | 29.838 | 20.103 |
| Current Assets | - | 16.836 | 6.809 | 8.314 | 10.906 | 12.401 | 17.873 | 30.332 | 37.319 | 4.660 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 304 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 16.532 | 6.809 | 8.314 | 10.906 | 12.401 | 17.873 | 30.332 | 37.319 | 4.660 |
| Shareholders Funds | - | 15.972 | 16.411 | 15.839 | 16.208 | 11.676 | 16.068 | 28.807 | 64.756 | 23.680 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 874 | 6.933 | 4.280 | 1.933 | 3.565 | 1.805 | 1.525 | 2.400 | 1.083 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ralvita Medical Srl